167 related articles for article (PubMed ID: 30264519)
1. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Cancer Med; 2018 Nov; 7(11):5775-5788. PubMed ID: 30264519
[TBL] [Abstract][Full Text] [Related]
2. An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Sci Rep; 2021 Apr; 11(1):7881. PubMed ID: 33846396
[TBL] [Abstract][Full Text] [Related]
3. The Epidemiology of Gastric Cancers in the Era of
Chang JS; Kuo SH; Chu PY; Shan YS; Tsai CR; Tsai HJ; Chen LT
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1694-1703. PubMed ID: 31350264
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted Therapy: A Nation-Wide Cancer Registry-Based Study From Taiwan.
Chang JS; Chen LT; Shan YS; Lin SF; Hsiao SY; Tsai CR; Yu SJ; Tsai HJ
Medicine (Baltimore); 2015 Jun; 94(24):e969. PubMed ID: 26091466
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
[TBL] [Abstract][Full Text] [Related]
7. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
8. Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
Pokrzywa CJ; Abbott DE; Matkowskyj KA; Ronnekleiv-Kelly SM; Winslow ER; Weber SM; Fisher AV
J Gastrointest Surg; 2019 Apr; 23(4):768-778. PubMed ID: 30706376
[TBL] [Abstract][Full Text] [Related]
9. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
[TBL] [Abstract][Full Text] [Related]
10. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.
Wyld D; Wan MH; Moore J; Dunn N; Youl P
Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715
[TBL] [Abstract][Full Text] [Related]
12. Life expectancy in pancreatic neuroendocrine cancer.
Brooks JC; Shavelle RM; Vavra-Musser KN
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):88-97. PubMed ID: 30220478
[TBL] [Abstract][Full Text] [Related]
13. Rare tumors of the colon and rectum: a national review.
Kang H; O'Connell JB; Leonardi MJ; Maggard MA; McGory ML; Ko CY
Int J Colorectal Dis; 2007 Feb; 22(2):183-9. PubMed ID: 16845516
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
[TBL] [Abstract][Full Text] [Related]
15. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.
Fitzgerald TL; Hickner ZJ; Schmitz M; Kort EJ
Pancreas; 2008 Aug; 37(2):134-8. PubMed ID: 18665072
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
[TBL] [Abstract][Full Text] [Related]
17. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
18. Incidence and survival of laryngeal cancer in Denmark: a nation-wide study from 1980 to 2014.
Nahavandipour A; Jakobsen KK; Grønhøj C; Hebbelstrup Jensen D; Kim Schmidt Karnov K; Klitmøller Agander T; Specht L; von Buchwald C
Acta Oncol; 2019 Jul; 58(7):977-982. PubMed ID: 30821560
[No Abstract] [Full Text] [Related]
19. Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.
Pinto MP; Muñoz Medel M; Carrillo D; Retamal IN; Bravo ML; Valenzuela Y; Nervi B; Sánchez C; Galindo H; Ibañez C; Peña J; Balmaceda C; Madrid J; Briones J; Torres J; Nilo F; Guarda FJ; Quintana JC; Orellana P; Mondaca S; Acevedo F; Vicentini D; Cordova-Delgado M; Owen GI; Garrido M
Horm Cancer; 2019 Feb; 10(1):3-10. PubMed ID: 30465145
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence of small bowel cancer according to histology: a population-based study.
Bouvier AM; Robaszkiewicz M; Jooste V; Cariou M; Drouillard A; Bouvier V; Nousbaum JB;
J Gastroenterol; 2020 Feb; 55(2):181-188. PubMed ID: 31630251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]